Malignant neoplasm of nipple and areola, male
- C50.02 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2024 edition of ICD-10-CM C50.02 became effective on October 1, 2023.
- This is the American ICD-10-CM version of C50.02 – other international versions of ICD-10 C50.02 may differ.
The following code(s) above C50.02 contain annotation back-references
that may be applicable to C50.02:
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
Diagnosis Index entries containing back-references to C50.02:
- Disease, diseased – see also Syndrome
- Paget’s disease
- breast (female) C50.01-
- male C50.02-
- malignant – see Neoplasm, skin, malignant
- breast (female) C50.01-
- male C50.02-
- unspecified site (female) C50.01-
- male C50.02-
- breast (female) C50.01-
- breast (female) C50.01-